MedCap AB (publ) logo

MCAP - MedCap AB (publ) Share Price

SEK227.5 -1.5  -0.7%

Last Trade - 4:04pm

Small Cap
Market Cap £288.3m
Enterprise Value £298.8m
Revenue £69.6m
Position in Universe 618th / 1829
Unlock MCAP Revenue
Relative Strength (%)
1m +8.66%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.98%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
816.9 851.7 533.3 709 757.1 817.4 964 1,031 +0.01%
+130.6 -96.9 +1,653 +130.8 +116.5 +6.4 +69.9 +18.1
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MedCapAB (publ) revenues increased 8% to SEK817.4M. Net incomebefore extraordinary items increased 13% to SEK62.6M.Revenues reflect Medical Technology segment increase of 12%to SEK482.6M, Specialty Pharmaceuticals segment increase of3% to SEK334.7M, Other European Countries segment increaseof 38% to SEK167.2M, Sweden segment increase of 4% toSEK461M, Other Foreign segment increase of 77% to SEK13.6M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


MCAP Revenue Unlock MCAP Revenue

Net Income

MCAP Net Income Unlock MCAP Revenue

Normalised EPS

MCAP Normalised EPS Unlock MCAP Revenue

PE Ratio Range

MCAP PE Ratio Range Unlock MCAP Revenue

Dividend Yield Range

MCAP Dividend Yield Range Unlock MCAP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MCAP EPS Forecasts Unlock MCAP Revenue
Profile Summary

MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since July 4, 2006
No. of Shareholders: n/a
No. of Employees: 353
Sector Financials
Industry Investment Banking & Investment Services
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 14,796,229
Free Float (0.0%)
Eligible for
MCAP Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for MCAP
Upcoming Events for MCAP
Frequently Asked Questions for MedCap AB (publ)
What is the MedCap AB (publ) share price?

As of 4:04pm, shares in MedCap AB (publ) are trading at SEK227.5, giving the company a market capitalisation of £288.3m. This share price information is delayed by 15 minutes.

How has the MedCap AB (publ) share price performed this year?

Shares in MedCap AB (publ) are currently trading at SEK227.5 and the price has moved by 18.65% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the MedCap AB (publ) price has moved by -11.26% over the past year.

What are the analyst and broker recommendations for MedCap AB (publ)?

Of the analysts with advisory recommendations for MedCap AB (publ), there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for MedCap AB (publ) is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will MedCap AB (publ) next release its financial results?

MedCap AB (publ) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the MedCap AB (publ) dividend yield?

MedCap AB (publ) does not currently pay a dividend.

Does MedCap AB (publ) pay a dividend?

MedCap AB (publ) does not currently pay a dividend.

When does MedCap AB (publ) next pay dividends?

MedCap AB (publ) does not currently pay a dividend.

How do I buy MedCap AB (publ) shares?

To buy shares in MedCap AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of MedCap AB (publ)?

Shares in MedCap AB (publ) are currently trading at SEK227.5, giving the company a market capitalisation of £288.3m.

Where are MedCap AB (publ) shares listed? Where are MedCap AB (publ) shares listed?

Here are the trading details for MedCap AB (publ):

Country of listing: Sweden
Exchange: STO
Ticker Symbol: MCAP
What kind of share is MedCap AB (publ)?

Based on an overall assessment of its quality, value and momentum, MedCap AB (publ) is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a MedCap AB (publ) share price forecast 2021?

Shares in MedCap AB (publ) are currently priced at SEK227.5. At that level they are trading at 90.52% premium to the analyst consensus target price of 0.00.

Analysts covering MedCap AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of 7.42 for the next financial year.

How can I tell whether the MedCap AB (publ) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MedCap AB (publ). Over the past six months, the relative strength of its shares against the market has been -16.46%. At the current price of SEK227.5, shares in MedCap AB (publ) are trading at 13.89% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the MedCap AB (publ) PE Ratio?

The MedCap AB (publ) PE ratio based on its reported earnings over the past 12 months is 52.43. The shares are currently trading at SEK227.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of MedCap AB (publ)?

MedCap AB (publ)'s management team is headed by:

Karl Tobieson - CEO
Anders Hansen - IND
Krister Sjoberg - CEX
Mats Thoren - IVM
Henrik Blomquist - DRC
Anders Edvell - CEX
Johan Hahnel - DIR
Renee Aguiar-Lucander - DRC
Henrik Koch - CFO
Peter von Ehrenheim - CHM
Anders Lundmark - DRC
Who are the major shareholders of MedCap AB (publ)?

Here are the top five shareholders of MedCap AB (publ) based on the size of their shareholding:

Julander (Bengt) Individual Investor
Percentage owned: 20.05% (2.97m shares)
Bure Equity AB Private Equity
Percentage owned: 9.84% (1.46m shares)
SEB Investment Management AB Investment Advisor
Percentage owned: 7.86% (1.16m shares)
Lannebo Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 7.46% (1.10m shares)
Avanza Bank Holding AB Corporation
Percentage owned: 5.36% (794k shares)
Similar to MCAP
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.